PubMed COVID-19 Clinical Care

The COVID-19 pandemic led to a rapid acceleration in the number of individuals engaging in remote work. This presented an opportunity to study individuals that were not voluntarily working remotely pre-pandemic and examine how they adapted and

CONCLUSION: This study indicates the importance of involvement in OSIG as a conduit for clinical exposure and mentorship throughout medical education, and is especially relevant for applicants given the impact of the COVID-19 pandemic on the

CONCLUSION: The proportion of long symptoms in COVID-19 with PTB survivors decreased over time, while nearly one in six still experience persistent symptoms with a higher proportion of anxiety. The recurrence of PTB and the psychological support of

The onset of the COVID-19 pandemic presented novel challenges for service providers addressing mental health issues with a large shift to the utilization of telehealth. While previous research has examined the benefits and challenges of providing

No abstract

Knowledge regarding the sustainability of immune responses after COVID-19 vaccination is important, e.g., to decide whom and when to booster. Thus, we analyzed antibody titers in firefighters six months after vaccination with the mRNA-based vaccine

CO (2) -based infection risk monitoring is highly recommended under the current COVID-19 pandemic. However, the C O 2 monitoring thresholds proposed in the literature are mainly for spaces with fixed occupants. Determining C O 2 threshold is

CONCLUSION: AI algorithms based on portable RX enabled a diagnostic performance comparable to human assessment for the detection of SARS-CoV-2 lung involvement.

The COVID-19 pandemic has posed enormous challenges for existing diagnostic tools to detect and monitor pathogens. Therefore, there is a need to develop point-of-care (POC) devices to perform fast, accurate, and accessible diagnostic methods to

Coronavirus disease 2019 (COVID-19) has become a major health burden worldwide, with over 600 million confirmed cases and 6 million deaths on 15 December 2022. Although the acute phase of COVID-19 management has been established, the long-term